Philadelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately Post author:Sam Post published:November 15, 2017 Post category:BioPharma The company is strengthening its team as it transitions to a clinical development stage company. Source: BioSpace You Might Also Like GlaxoSmithKline Poaches AstraZeneca PLC Exec to Replace Exiting Pharma Head January 18, 2017 3 Biotechs That Could Outperform in 2018 January 4, 2018 Agios, Celgene Win Early FDA Approval for New Cancer Drug July 31, 2017